NeuCyte Competitors and Similar CompaniesClear all
NeuCyte's competitors and similar companies include Memo Therapeutics and Accellix.
 Memo Therapeutics Memo Therapeutics is a company operating in the field of antibody discovery and immune repertoire analysis. |  Accellix Accellix (formerly known as LeukoDx) is a biotechnology company developing a platform to enable its customers in the field of cell and gene therapy to meet their quality control requirements. | ||
Founding Date | Founding Date 2015 | Founding Date 2012 | Founding Date 2007 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations San Carlos, US HQ | Locations Schlieren, CH HQ | Locations San Jose, US HQ Jerusalem, IL |
Employees | Employees 148% increase | Employees 452% increase | Employees 663% decrease |
Funding | |||
Latest funding round | Latest funding round $ 6.7m (about 8 years ago) | Latest funding round $ 27.7m (over 2 years ago) | Latest funding round $ 9.5m (about 6 years ago) |
Total funding raised | Total funding raised $ 6.7m | Total funding raised $ 50.5m | Total funding raised $ 18m |
For sources of this data, please see the company profile
View Company Profiles
Memo Therapeutics
HQ
Schlieren, CH
Employees
45↑ 2% increase
Memo Therapeutics is a company operating in the field of antibody discovery and immune repertoire analysis.
View companyAccellix
HQ
San Jose, US
Employees
66↓ 3% decrease
Accellix (formerly known as LeukoDx) is a biotechnology company developing a platform to enable its customers in the field of cell and gene therapy to meet their quality control requirements.
View company